Howe & Rusling’s Assembly Biosciences ASMB Stock Holding History

Howe & Rusling’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2	Closed	-$1K	–	818
2018 Q3	$1K	Buy	+2	New	+$937	﹤0.01%	762

Other funds holding ASMB

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Howe & Rusling's ASMB Position: Q4 2018 in Review

Howe & Rusling sold out of Assembly Biosciences (ASMB) in Q4 2018, closing a stake of 2 shares — an estimated $1K sold.

Howe & Rusling first reported a position in ASMB in Q3 2018 and held it in 1 quarter. The position peaked at $1K in Q3 2018. 106 funds tracked by Wall St. Rank hold ASMB as of Q4 2018.

Howe & Rusling reported no remaining Assembly Biosciences position as of Q4 2018 after selling out during the quarter.
Howe & Rusling sold 2 Assembly Biosciences shares in Q4 2018, an estimated $1K.
Howe & Rusling first reported a position in Assembly Biosciences in Q3 2018 and held it in 1 quarter.
Howe & Rusling's Assembly Biosciences position peaked at $1K in Q3 2018.
106 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2018.

Based on Howe & Rusling's 13F filing for Q4 2018, filed 4 Feb 2019.